The United Kingdom’s weight-loss medication market has witnessed an unprecedented surge, with more than 500,000 individuals now utilising revolutionary anti-obesity drugs Mounjaro and Wegovy. This dramatic increase has occurred within
The United Kingdom’s weight-loss medication market has witnessed an unprecedented surge, with more than 500,000 individuals now utilising revolutionary anti-obesity drugs Mounjaro and Wegovy. This dramatic increase has occurred within
Finnish health-tracking smart ring manufacturer Ōura has secured a remarkable £200 million in fresh funding, propelling its valuation to £5.2 billion—twice its 2022 value. This investment round stands as one
Leading scientists have raised grave concerns about the existential threat posed by ‘mirror life’ – artificially created bacteria that could potentially overwhelm Earth’s natural defence systems. A distinguished group of
A significant shift in consumer awareness regarding ultra-processed foods (UPFs) is emerging as the festive season approaches, with shoppers becoming increasingly conscious of their dietary choices. This heightened scrutiny comes
In a sweeping move to combat childhood obesity, the UK government has announced that its forthcoming junk food advertising ban will encompass a broader range of everyday food items, including
In a significant move towards addressing gambling-related harm, the British Labour government is preparing to implement a mandatory £100 million annual levy on gambling companies. The initiative, expected to be
The treatment of lung cancer has improved over the years, but doctors can still’t predict what patients will do following surgery. About half of the patients whose tumors were “advanced,
A report from a group of academics and public health organizations claims that the sponsorship of Formula 1 by the tobacco industry could “drive addiction” to nicotine and cigarettes among
The largest pharmaceutical company in Britain has signed a license agreement with a Chinese firm that could be worth up to $ 2 billion. This is to develop a drug
AstraZeneca’s acquisition of a cancer drug for up to $1billion has been marred by disappointing results in late-stage trials, causing yet another clinical setback. The FTSE100 company stated that phase
Leading experts in the UK have warned that there will be a “tsunami” of cancers missed, following an international study which found that diagnosis rates dropped sharply during this pandemic.
A left-of centre think-tank said that the government should invest £15bn per year in a radical reform programme designed to improve national prosperity and wellbeing. The Institute for Public Policy
AstraZeneca has suffered a setback after disappointing late-stage results from a lung cancer drug that was closely monitored. The FTSE-100 pharmaceutical company showed its confidence in Dato-DXd when it presented
A shortage of chemicals that are used to detect prostate and bone tumors is putting patients at risk. This is due to the slowdown in imports, a lack of funding
Wes Streeting said that the NHS must make three “big changes” to its delivery of care in order to have a sustainable future. The UK Health and Social Care Secretary
Linda Medendorp learned that she would die the day her son turned 18. Tests revealed that after a 51-year old woman complained of persistent swallowing problems, she had an incurable